In Brief This Week: PacBio; Great Basin; Epigenomics; and More | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Biosciences announced this week that BGI has acquired its first Sequel System from PacBio. BGI also plans to purchase additional units in order to further integrate SMRT Sequencing into its global service business, the company added. PacBio also recently received ISO 13485 and ISO 9001 certifications for the design, development, manufacture, distribution, installation, and servicing of its nucleic acid sequencing platforms from the International Organization for Standardization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.